Trial updateRetina

A Phase 2 Study of NT-101 Topical in Patients With Wet AMD

Recruiting. Phase 2. Registered enrolment: 66. NexThera Co., Ltd.

Close-up of the iris and pupil
Stock photo · Colin Lloyd / Unsplash

Why it matters

Track this study through NCT07811726. No results are posted in this registry record.

The study at a glance

Registry status
Recruiting
Phase
Phase 2
Registered enrolment
66
Results posted
No
Sponsor
NexThera Co., Ltd.

Keep in mind

Registry information describes the study; recruitment status alone does not establish efficacy or safety.

References (1)
  1. ClinicalTrials.gov · NCT07811726

Source date: 16 Sept 2026 · United States

Report a correction

Connected reading